FDA
-
-
-
-
-
-
-
Respira Therapeutics Enters into Agreement with Gossamer Bio (Gossamer) Granting Gossamer Option to Acquire Respira from Samsara BioCapital
-
-
-
-
-
-
-
Gossamer Bio Announces TORREY Data to be Featured at American Thoracic Society 2023 International Conference
-
-
-
-
-
-
-
Gossamer Bio Announces Fourth Quarter and Full-Year 2020 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Aerpio Pharmaceuticals, Inc. and Quantum Leap Healthcare Collaborative Announce the Selection of Razuprotafib for Evaluation in the I-SPY COVID Trial for the Treatment of Acute Respiratory Distress Sy
-
-
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

